| James E Dowd, MD | |
|
10484 Citation Dr, Suite 100, Brighton, MI 48116-6565 | |
| (810) 225-7553 | |
| (810) 225-7558 |
| Full Name | James E Dowd |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 37 Years |
| Location | 10484 Citation Dr, Brighton, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750482162 | NPI | - | NPPES |
| 3288784 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | JD066359 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Entity Name | James E Dowd Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619157583 PECOS PAC ID: 5294766218 Enrollment ID: O20050829000942 |
News Archive
Alba Therapeutics Corporation announced today it will initiate further clinical studies for patients diagnosed with celiac disease with their lead compound, larazotide acetate.
Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.
Eating a healthy diet and drinking a moderate amount of alcohol may be associated with decreased risk or progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James E Dowd, MD 10484 Citation Dr, Suite 100, Brighton, MI 48116-6565 Ph: (810) 225-7553 | James E Dowd, MD 10484 Citation Dr, Suite 100, Brighton, MI 48116-6565 Ph: (810) 225-7553 |
News Archive
Alba Therapeutics Corporation announced today it will initiate further clinical studies for patients diagnosed with celiac disease with their lead compound, larazotide acetate.
Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.
Eating a healthy diet and drinking a moderate amount of alcohol may be associated with decreased risk or progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.
› Verified 8 days ago
Thomas P Scott-craig, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8001 Challis Road, Brighton, MI 48116 Phone: 810-227-9510 | |
Mark J Skalski, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 8001 Challis Rd, Brighton, MI 48116 Phone: 810-227-9510 | |
Amanda Marie Cox, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8001 Challis Rd, Brighton, MI 48116 Phone: 810-227-9510 | |
Linda Carol Lachance, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2209 Euler Rd, #1, Brighton, MI 48114 Phone: 810-225-7960 Fax: 810-225-7961 | |
Kelsey Marie Lemmen, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8001 Challis Rd, Brighton, MI 48116 Phone: 734-998-2020 | |
Mark William Ealovega, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8001 Challis Rd, Brighton, MI 48116 Phone: 810-227-9510 | |
Veta Amy Ruck, CFNP Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 136 Kissane, Brighton, MI 48116 Phone: 810-225-2331 |